Simplex Trading
KRYS icon

Simplex Trading’s Krystal Biotech KRYS Stock Holding History

Simplex Trading’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$818K Buy
2,200
+1,600
+267% +$478K ﹤0.01% 2999
2026
Q1 		$155K Buy
600
+500
+500% +$133K ﹤0.01% 4603
2025
Q4 		$24.7K Sell
100
-200
-67% -$42.1K ﹤0.01% 6281
2025
Q3 		$52K Sell
300
-7,900
-96% -$1.18M ﹤0.01% 6417
2025
Q2 		$1.13M Buy
+8,200
New +$1.2M ﹤0.01% 2652
2025
Q1 		– Sell
-1,000
Closed -$156K – 9101
2024
Q4 		$156K Sell
1,000
-8,100
-89% -$1.44M ﹤0.01% 4753
2024
Q3 		$1.66M Buy
9,100
+8,200
+911% +$1.58M ﹤0.01% 2445
2024
Q2 		$165K Sell
900
-41,000
-98% -$6.88M ﹤0.01% 4835
2024
Q1 		$7.46M Buy
41,900
+7,200
+21% +$1M ﹤0.01% 1311
2023
Q4 		$4.3M Buy
34,700
+33,600
+3,055% +$3.73M ﹤0.01% 1691
2023
Q3 		$127K Sell
1,100
-1,500
-58% -$183K ﹤0.01% 4844
2023
Q2 		$305K Sell
2,600
-14,400
-85% -$1.47M ﹤0.01% 3822
2023
Q1 		$1.36M Buy
17,000
+16,400
+2,733% +$1.29M ﹤0.01% 2299
2022
Q4 		$47K Hold
600
– – ﹤0.01% 5966
2022
Q3 		$41K Sell
600
-16,700
-97% -$1.21M ﹤0.01% 6706
2022
Q2 		$1.14M Buy
17,300
+14,100
+441% +$877K ﹤0.01% 2479
2022
Q1 		$212K Sell
3,200
-8,300
-72% -$518K ﹤0.01% 5076
2021
Q4 		$804K Buy
11,500
+11,400
+11,400% +$664K ﹤0.01% 3165
2021
Q3 		$7K Hold
100
– – ﹤0.01% 9112
2021
Q2 		$6K Buy
100
+69
+223% +$4.82K ﹤0.01% 9377
2021
Q1 		$238K Buy
31
+5
+19% +$364 ﹤0.01% 4485
2020
Q4 		$156K Buy
+26
New +$1.3K ﹤0.01% 4935

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Simplex Trading's KRYS Position: Q2 2026 in Review

Simplex Trading sold out of Krystal Biotech (KRYS) in Q2 2026, closing a stake of 50 shares — an estimated $14.9K sold.

Simplex Trading first reported a position in KRYS in Q2 2020 and held it in 9 quarters. The position peaked at $609K in Q2 2023. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Simplex Trading reported no remaining Krystal Biotech position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 50 Krystal Biotech shares in Q2 2026, an estimated $14.9K.
  • Simplex Trading first reported a position in Krystal Biotech in Q2 2020 and held it in 9 quarters.
  • Simplex Trading's Krystal Biotech position peaked at $609K in Q2 2023.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.